Surgery Partners (SGRY) Change in Receivables (2014 - 2026)

Surgery Partners has disclosed Change in Receivables across 13 years of filings, most recently posting $15.0 million for Q2 2026.

• In Q2 2026, Change in Receivables rose 505.41% year-over-year to $15.0 million; the TTM figure through Jun 2026 stood at $73.7 million (up 43.11% YoY), while the FY2025 annual figure was $53.8 million, down 25.38% from the prior year.
• Change in Receivables came in at $15.0 million for Q2 2026 at Surgery Partners, up from -$3.6 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $46.1 million in Q4 2025 to a low of -$8.8 million in Q1 2023.
• Average Change in Receivables over 5 years is $12.2 million, with a median of $13.5 million recorded in 2023.
• The largest YoY upside for Change in Receivables was 555.0% in 2023 against a maximum downside of 340.0% in 2023.
• Over 5 years, Change in Receivables stood at $38.7 million in 2022, then dropped by 25.06% to $29.0 million in 2023, then jumped by 41.03% to $40.9 million in 2024, then increased by 12.71% to $46.1 million in 2025, then plunged by 67.46% to $15.0 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $15.0 million in Q2 2026, -$3.6 million in Q1 2026, and $46.1 million in Q4 2025.